86 related articles for article (PubMed ID: 32535305)
1. A bubble bursting-mediated oral drug delivery system that enables concurrent delivery of lipophilic and hydrophilic chemotherapeutics for treating pancreatic tumors in rats.
Chen KH; Miao YB; Shang CY; Huang TY; Yu YT; Yeh CN; Song HL; Chen CT; Mi FL; Lin KJ; Sung HW
Biomaterials; 2020 Oct; 255():120157. PubMed ID: 32535305
[TBL] [Abstract][Full Text] [Related]
2. N-Deoxycholic acid-N,O-hydroxyethyl Chitosan with a Sulfhydryl Modification To Enhance the Oral Absorptive Efficiency of Paclitaxel.
Yu Y; Huo M; Fu Y; Xu W; Cai H; Yao L; Chen Q; Mu Y; Zhou J; Yin T
Mol Pharm; 2017 Dec; 14(12):4539-4550. PubMed ID: 29058910
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.
Yang FH; Zhang Q; Liang QY; Wang SQ; Zhao BX; Wang YT; Cai Y; Li GF
Molecules; 2015 Mar; 20(3):4337-56. PubMed ID: 25756651
[TBL] [Abstract][Full Text] [Related]
4. DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy.
Jang E; Son M; Jang J; Lee IH; Kim S; Kwon T; Jeon YH; Koh WS; Kim KS; Kim SK
PLoS One; 2019; 14(11):e0225095. PubMed ID: 31743348
[TBL] [Abstract][Full Text] [Related]
5. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
6. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer.
Shanmugam T; Joshi N; Ahamad N; Deshmukh A; Banerjee R
Int J Pharm; 2020 Aug; 586():119482. PubMed ID: 32492505
[TBL] [Abstract][Full Text] [Related]
7. Oral metronomic therapy of pancreatic cancer with gemcitabine and paclitaxel co-loaded in lecithin-based Self-Nanoemulsifying preconcentrate (
Lin CJ; Cheng WT; Chen LC; Chen TL; Sheu MT; Lin HL
Int J Pharm; 2023 Oct; 645():123370. PubMed ID: 37666310
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy.
Le Z; Chen Y; Han H; Tian H; Zhao P; Yang C; He Z; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42186-42197. PubMed ID: 30444601
[TBL] [Abstract][Full Text] [Related]
9. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
10. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H
Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of carboxymethyl chitosan-rhein polymeric micelles with synergistic antitumor effect for oral delivery of paclitaxel.
Wang X; Guo Y; Qiu L; Wang X; Li T; Han L; Ouyang H; Xu W; Chu K
Carbohydr Polym; 2019 Feb; 206():121-131. PubMed ID: 30553305
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel's Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis.
Sun H; Bhandari K; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563165
[TBL] [Abstract][Full Text] [Related]
14. Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy.
Chen T; Tu L; Wang G; Qi N; Wu W; Zhang W; Feng J
Int J Pharm; 2020 Mar; 578():119105. PubMed ID: 32018019
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacy.
Zhai Z; Xu P; Yao J; Li R; Gong L; Yin Y; Lin Z
Drug Deliv; 2020 Dec; 27(1):387-399. PubMed ID: 32098525
[TBL] [Abstract][Full Text] [Related]
17. Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.
Gupta R; Shea J; Scafe C; Shurlygina A; Rapoport N
J Control Release; 2015 Aug; 212():70-7. PubMed ID: 26091919
[TBL] [Abstract][Full Text] [Related]
18. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH
Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930
[TBL] [Abstract][Full Text] [Related]
19. The enhancing effect of N-acetylcysteine modified hyaluronic acid-octadecylamine micelles on the oral absorption of paclitaxel.
Zhang M; Asghar S; Jin X; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
Int J Biol Macromol; 2019 Oct; 138():636-647. PubMed ID: 31330211
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of intestinal permeation enhancement with carboxymethyl chitosan-rhein polymeric micelles for oral delivery of paclitaxel.
Wang X; Qiu L; Wang X; Ouyang H; Li T; Han L; Zhang X; Xu W; Chu K
Int J Pharm; 2020 Jan; 573():118840. PubMed ID: 31715358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
